Rare diseases are classified as any disease that affects less than 200,000 Americans. Orphan diseases, including rare diseases, are neglected conditions whose treatments are often not considered profitable due to their cost to develop and limited patient population.
The Orphan Drug Act is a law passed by Congress in 1983 that incentivizes the development of drugs to treat rare diseases. Companies and other drug developers can request orphan drug designation and the FDA will grant such designation if the drug meets specific criteria.
Specialty pharmacies play a crucial role in the management of rare diseases, offering specialized services and support tailored to the unique needs of patients facing these conditions.
Centers of Excellence (CoE) were designed to improve the reach of critical expertise throughout the organization, regardless of geographical location or business unit.
CoEs exist in a range of versions within many industries and companies. Specialty pharmacy CoEs are most often developed for therapies and disease states to create value in specific areas of clinical expertise.
The Rare Disease Specialty Pharmacy Centers of Excellence Report offers comprehensive intelligence on over 30 specialty pharmacies that offer Centers of Excellence to treat rare disease patients. The report provides a profile for each pharmacy that includes: company background, strategy, top executives, financial/investor information, products and services, and recent activities.
Report Table of Contents
Introduction – pgs. 4-6
Specialty Pharmacy Center of Excellence Profiles
- Accredo Health Group – pgs. 8-12
- Amber Specialty Pharmacy – pgs. 13-15
- AnovoRx – pgs. 16-19
- Biologics by McKesson – pgs. 20-23
- Blue Sky Specialty Pharmacy – pgs. 24-26
- CareMed Specialty Pharmacy/Onco360 – pgs. 27-30
- CenterWell Specialty Pharmacy/Humana – pgs. 31-34
- Chemistry Rx – pgs. 35-36
- CVS Specialty Pharmacy – pgs. 37- 41
- Fairview Specialty Pharmacy – pgs. 42-45
- Gentry Health Services – pgs. 46-48
- InfuCare Rx – pgs. 49-51
- Lumicera Health Services – pgs. 52-54
- Maxor National Pharmacy Services – pgs. 55-57
- MUSC Health Specialty Pharmacy – pgs. 58-59
- Optum Frontier Therapies – pgs. 60-66
- Orsini Specialty Pharmacy – pgs. 67-70
- PANTHERx Rare Pharmacy – pgs. 71-75
- PerformSpecialty – pgs. 76-77
- Pharmacy Advantage Specialty Pharmacy – pgs. 78-80
- PromptCare – pgs. 81-84
- Signio Rare & Complex/PolarisRx – pgs. 85-87
- Soleo Health – pgs. 88-91
- Special Care Pharmacy Services – pgs. 92-94
- UI Health Care Specialty Pharmacy – pgs. 95-96
- UK HealthCare Specialty Pharmacy – pgs. 97-98
- UVA Health Specialty Pharmacy – pgs. 99-100
- Vanderbilt Specialty Pharmacy – pgs. 101-103
- Vanscoy Rare Pharmacy – pgs. 104-107
- Walgreens Specialty Pharmacy – pgs. 108-112
- Zeal Specialty Pharmacy – pgs. 113-115
AMI monitors and reports on specialty pharmacies through the industry’s most comprehensive Specialty Pharmacy Database. The database, with approximately 1,775 locations, updates current records and adds new records daily.